查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530035

製药 4.0 市场规模、份额和趋势分析报告：2024-2030 年按类型、技术、最终用途、地区和细分市场进行的预测

Pharma 4.0 Market Size, Share & Trends Analysis Report By Type (Software, Services), By Technology (AI/ML, Big Data Analytics, IoT, Blockchain Technology), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

製药 4.0 市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球医药4.0市场规模将达到357.9亿美元，2024年至2030年复合年增长率为18.96%。

製药 4.0 市场由几个关键因素推动，包括对个人化医疗的需求不断增长、对提高效率和降低成本的需求、供应链优化以及对以患者为中心的方法的日益关注。慢性病和罕见疾病的盛行率不断上升，增加了对个人化医疗的需求。积层製造（3D 列印）和模组化生产设备等製药 4.0 技术透过实现个人化药品和小批量生产以满足患者个别需求，正在推动这一趋势。

此外，数位技术的不断采用也促进了市场的成长。这些技术优化、改进和转变药物开发、製造、分销和患者照护。区块链技术透过提供透明度、可追溯性和优化、减少缺货、防止假冒以及提高整体效率和病患安全，正在大幅重新构想供应链管理。

此外，製药公司对采用 Pharma 4.0 技术的投资增加也推动了市场成长。例如，Astra Zeneca签署了一份价值高达8.4亿美元的合同，用于罕见神经退化性疾病和神经肌肉疾病的靶点识别。作为协议的一部分，Astra Zeneca的 Alexion 部门将与 Verge Genomics 合作，确定这些疾病的药物标靶。在这项为期四年的多目标协议中，两家公司将使用机器学习来分析 Verge 的基因组资料集，这些资料集来自人体组织而不是细胞或动物模型。

製药 4.0 市场报告亮点

  • 按产品类型划分，由于效率提高、合规性提高和生产力提高等各种优势，软体的采用率不断提高，因此软体细分市场将在 2023 年占据市场主导地位。此外，支援物联网的软体有助于即时监控和追踪製造流程，从而实现更好的製程控制并减少停机时间。
  • 从技术角度来看，由于人工智慧采用的扩大和投资的增加，人工智慧和机器学习领域占据了最大的市场占有率。例如，一项调查发现，超过 75% 的製药高管计划在 2025 年应用人工智慧来加速药物发现。
  • 从应用来看，由于药物新兴企业对人工智慧的投资增加，药物发现和市场开拓在 2023 年占据市场主导地位。
  • 2023年，製药和生物技术领域占最大的市场占有率，达到49.8%。製药公司越来越多地采用 Pharma 4.0 技术，以提高製造流程的效率、生产力和质量，这推动了该领域的成长。
  • 2023年，北美地区以41.12%的收益占有率主导全球市场。这一增长归功于政府主导的加强、医疗保健行业的技术进步以及主要市场参与者的强大影响力。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 製药 4.0 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 製药4.0市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 的影响

第 4 章 製药 4.0 市场：按类型估计和趋势分析

  • 2023 年和 2030 年按类型分類的市场占有率
  • 细分仪表板
  • 按类型：全球製药 4.0 市场展望
  • 软体
  • 服务

第五章 製药4.0市场：技术预估与趋势分析

  • 2023年及2030年技术市场占有率
  • 细分仪表板
  • 科技展：全球製药4.0市场回顾
  • 人工智慧和机器学习
  • 巨量资料分析
  • IoT
  • 区块链技术
  • 其他（数位双胞胎、先进机器人、AR 和 VR）

第六章 製药 4.0 市场：依应用估算与趋势分析

  • 2023 年和 2030 年按应用分類的市场占有率
  • 细分仪表板
  • 按应用分：全球製药4.0市场展望
  • 药物发现与开发
  • 製造业
  • 供应链管理
  • 其他（产品生命週期管理、个人化医疗、法规遵循）

第七章 製药 4.0 市场：依最终用途分类的估算与趋势分析

  • 2023 年和 2030 年按最终用途分類的市场占有率
  • 细分仪表板
  • 按最终用途分類的全球製药 4.0 市场展望
  • 製药和生物技术公司
  • 医疗服务提供方
  • CRO 和 CDMO

第八章 製药 4.0 市场：按地区、类型、技术、应用、最终用途进行估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 2023年主要企业市场占有率分析
  • 公司简介
    • Microsoft Corporation
    • IBM
    • Amazon Web Service（AWS）
    • SAP
    • Oracle
    • GE Healthcare
    • Siemens Healthineers
    • Cisco
    • Cinntra
    • Dassault Systems
    • Nexocode
Product Code: GVR-4-68040-385-0

Pharma 4.0 Market Growth & Trends:

The global pharma 4.0 market size is expected to reach USD 35.79 billion by 2030, registering a CAGR of 18.96% from 2024 to 2030, according to a new report by Grand View Research, Inc. The pharma 4.0 market is being driven by several key factors, including the rising demand for personalized medicine, the need for improved efficiency and cost reduction, supply chain optimization, and an increasing focus on patient-centric approaches. The growing prevalence of chronic disorders and rare diseases has heightened the demand for personalized medicine. Pharma 4.0 technologies, such as additive manufacturing (3D printing) and modular production facilities, enable the production of personalized medicines and small batches tailored to individual patient needs, supporting this trend.

In addition, increasing adoption of digital technologies is driving the market growth. These technologies optimize, improve, and revolutionize drug development, manufacturing, distribution, and patient care. Blockchain technology has significantly reshaped supply chain management by offering transparency, traceability, and optimization, reducing stockouts, preventing counterfeiting, and enhancing overall efficiency and patient safety.

Furthermore, the market growth is being driven by increasing investments from pharmaceutical companies in adopting Pharma 4.0 technologies. For example, AstraZeneca signed a deal worth up to USD 840 million for the target identification of rare neurodegenerative and neuromuscular diseases. As part of this deal, AstraZeneca's Alexion division will collaborate with Verge Genomics to identify drug targets for these conditions. Over the course of the four-year, multi-target agreement, the companies will utilize machine learning to analyze Verge's genomic datasets, which are derived from human tissue rather than cell or animal models.

Pharma 4. 0 Market Report Highlights:

  • On the basis of type, the software segment dominated the market in 2023, owing to the increasing adoption of software due to various benefits such as efficiency enhancement, improved compliance and productivity. In addition, the IoT enabled software help in real time monitoring and tracking of manufacturing process, leading to better process control and reduces the downtime
  • On the basis of technology, the AI & ML segment held the largest market share owing to growing adoption of AI and increasing investments. For instance, as per a survey, over 75% of pharma executives plan to apply AI to speed drug discovery by 2025
  • On the basis of application, the drug discovery & development dominated the market in 2023 due to increased investment in AI for drug discovery startups
  • Pharma & biotech segment held the largest market share of 49.8% in 2023. Pharmaceutical companies are increasingly adopting Pharma 4.0 technologies to enhance efficiency, productivity, and quality in their manufacturing processes thereby driving the segment growth
  • North America dominated the global market with a revenue share of 41.12% in 2023. The growth is attributed to the increasing government initiative, technological advancement in the healthcare industry, and a strong presence of key market players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Technology
    • 1.1.3. Application
    • 1.1.4. End Use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharma 4.0 Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Pharma 4.0 Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. COVID-19 Impact

Chapter 4. Pharma 4.0 Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Pharma 4.0 Market by Type Outlook
  • 4.4. Software
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 4.5. Services
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Pharma 4.0 Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Pharma 4.0 Market by Technology Outlook
  • 5.4. AI & ML
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 5.5. Big Data Analytics
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 5.6. IoT
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 5.7. Block chain Technology
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 5.8. Others (Digital twin, Advanced robotics, AR &VR)
    • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Pharma 4.0 Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Pharma 4.0 Market by Application Outlook
  • 6.4. Drug Discovery & Development
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 6.5. Manufacturing
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 6.6. Supply Chain Management
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 6.7. Others (Product Lifecycle Management, Personalized Medicine, Regulatory Compliance)
    • 6.7.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 7. Pharma 4.0 Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Pharma 4.0 Market by End Use Outlook
  • 7.4. Pharma & Biotech companies
    • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 7.5. Healthcare Providers
    • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 7.6. CRO & CDMO
    • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 8. Pharma 4.0 Market: Regional Estimates & Trend Analysis, By type, By technology, By Application, By End Use

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Key company market share analysis, 2023
  • 9.4. Company Profiles
    • 9.4.1. Microsoft Corporation
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. IBM
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Amazon Web Service (AWS)
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. SAP
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Oracle
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. GE Healthcare
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Siemens Healthineers
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Cisco
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Cinntra
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Dassault Systems
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Nexocode
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Pharma 4.0 Market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 9 U.S. Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 10 U.S. Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 13 Canada Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mexico Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 16 Mexico Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Mexico Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe Pharma 4.0 Market, by region, 2018 - 2030 (USD Million)
  • Table 20 Europe Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Europe Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 25 Germany Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Germany Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 28 UK Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 29 UK Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 30 UK Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 31 UK Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 32 France Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 33 France Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 34 France Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 35 France Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Italy Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 37 Italy Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Italy Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 39 Italy Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Spain Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 41 Spain Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Spain Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 43 Spain Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 45 Denmark Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Denmark Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 47 Denmark Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Sweden Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 49 Sweden Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Sweden Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 51 Sweden Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Norway Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 53 Norway Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Norway Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 55 Norway Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Pharma 4.0 Market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 61 China Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 62 China Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 63 China Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 64 China Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Japan Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 66 Japan Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Japan Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 68 Japan Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 69 India Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 70 India Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 71 India Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 72 India Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 73 South Korea Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 74 South Korea Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 75 South Korea Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 76 South Korea Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Australia Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 78 Australia Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 79 Australia Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 80 Australia Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Thailand Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 82 Thailand Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Thailand Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 84 Thailand Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Latin America Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 86 Latin America Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 87 Latin America Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 88 Latin America Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Brazil Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 90 Brazil Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 91 Brazil Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 92 Brazil Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Argentina Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 94 Argentina Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 95 Argentina Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 96 Argentina Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 97 MEA Pharma 4.0 Market, by region, 2018 - 2030 (USD Million)
  • Table 98 MEA Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 99 MEA Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 100 MEA Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 101 MEA Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 102 South Africa Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 103 South Africa Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 104 South Africa Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 105 South Africa Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 110 UAE Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 111 UAE Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 112 UAE Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 113 UAE Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)
  • Table 114 Kuwait Pharma 4.0 Market, by type, 2018 - 2030 (USD Million)
  • Table 115 Kuwait Pharma 4.0 Market, by technology, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Pharma 4.0 Market, by application, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Pharma 4.0 Market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Pharma 4.0 Market: market outlook
  • Fig. 9 Cryostat competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Pharma 4.0 Market driver impact
  • Fig. 15 Pharma 4.0 Market restraint impact
  • Fig. 16 Pharma 4.0 Market strategic initiatives analysis
  • Fig. 17 Pharma 4.0 Market: Type movement analysis
  • Fig. 18 Pharma 4.0 Market: Type outlook and key takeaways
  • Fig. 19 Software market estimates and forecast, 2018 - 2030
  • Fig. 20 Services market estimates and forecast, 2018 - 2030
  • Fig. 21 Pharma 4.0 Market: Technology movement analysis
  • Fig. 22 Pharma 4.0 Market: Technology outlook and key takeaways
  • Fig. 23 AI & ML market estimates and forecast, 2018 - 2030
  • Fig. 24 Big data analytics market estimates and forecast, 2018 - 2030
  • Fig. 25 IoT market estimates and forecast, 2018 - 2030
  • Fig. 26 Block chain technology market estimates and forecast, 2018 - 2030
  • Fig. 27 Others market estimates and forecast, 2018 - 2030
  • Fig. 28 Pharma 4.0 Market: Application movement analysis
  • Fig. 29 Pharma 4.0 Market: Application outlook and key takeaways
  • Fig. 30 Drug Discovery & Development market estimates and forecast, 2018 - 2030
  • Fig. 31 Manufacturing market estimates and forecast, 2018 - 2030
  • Fig. 32 Supply Chain Management market estimates and forecast, 2018 - 2030
  • Fig. 33 Others market estimates and forecast, 2018 - 2030
  • Fig. 34 Pharma 4.0 Market: End Use movement analysis
  • Fig. 35 Pharma 4.0 Market: End Use outlook and key takeaways
  • Fig. 36 Pharma & Biotech companies market estimates and forecast, 2018 - 2030
  • Fig. 37 Healthcare providers market estimates and forecast, 2018 - 2030
  • Fig. 38 CRO & CDMO market estimates and forecast, 2018 - 2030
  • Fig. 39 Global Pharma 4.0 Market: Regional movement analysis
  • Fig. 40 Global Pharma 4.0 Market: Regional outlook and key takeaways
  • Fig. 41 Global Pharma 4.0 Market share and leading players
  • Fig. 42 North America market share and leading players
  • Fig. 43 Europe market share and leading players
  • Fig. 44 Asia Pacific market share and leading players
  • Fig. 45 Latin America market share and leading players
  • Fig. 46 Middle East & Africa market share and leading players
  • Fig. 47 North America: SWOT
  • Fig. 48 Europe SWOT
  • Fig. 49 Asia Pacific SWOT
  • Fig. 50 Latin America SWOT
  • Fig. 51 MEA SWOT
  • Fig. 52 North America, by country
  • Fig. 53 North America market estimates and forecasts, 2018 - 2030
  • Fig. 54 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 55 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 57 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 58 UK market estimates and forecasts, 2018 - 2030
  • Fig. 59 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 60 France market estimates and forecasts, 2018 - 2030
  • Fig. 61 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 62 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 63 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 64 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 65 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 66 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 67 China market estimates and forecasts, 2018 - 2030
  • Fig. 68 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 69 India market estimates and forecasts, 2018 - 2030
  • Fig. 70 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 71 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 72 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 73 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 75 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 76 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 77 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 78 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 79 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 80 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 81 Market share of key market players- Pharma 4.0 Market